Market Currents
Vertex Pharmaceuticals (VRTX -12.3%) slides on weaker-than-expected Q3 results and a downgrade...
-
Friday, November 2, 2012, 1:55 PM ETVertex Pharmaceuticals (VRTX -12.3%) slides on weaker-than-expected Q3 results and a downgrade to Neutral by Goldman. Citing the weak results and the recent NACFC conference, Goldman says it's formed a more cautious outlook on the company's key pipeline program, and sees a limited number of upside catalysts heading into 2013.
Other date
Latest Earnings Articles
